These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21840242)

  • 1. Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test.
    Kikuchi A; Baba T; Hasegawa T; Sugeno N; Konno M; Takeda A
    Parkinsonism Relat Disord; 2011 Nov; 17(9):698-700. PubMed ID: 21840242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
    Izawa MO; Miwa H; Kajimoto Y; Kondo T
    Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].
    Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Ortega-Léon T; Gallego-Peinado M; Cabello-García D; Gómez Río M; Ortega-Moreno A; Carnero-Pardo C; Rebollo-Aguirre AC; Mínguez-Castellanos A
    Neurologia; 2009 Apr; 24(3):170-6. PubMed ID: 19418293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory function combined with morphology distinguishes Parkinson's disease.
    Sengoku R; Matsushima S; Bono K; Sakuta K; Yamazaki M; Miyagawa S; Komatsu T; Mitsumura H; Kono Y; Kamiyama T; Ito K; Mochio S; Iguchi Y
    Parkinsonism Relat Disord; 2015 Jul; 21(7):771-7. PubMed ID: 25986741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
    Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
    J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy.
    Suzuki M; Hashimoto M; Yoshioka M; Murakami M; Kawasaki K; Urashima M
    BMC Neurol; 2011 Dec; 11():157. PubMed ID: 22192419
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
    J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
    Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
    Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.
    Treglia G; Stefanelli A; Cason E; Cocciolillo F; Di Giuda D; Giordano A
    Clin Neurol Neurosurg; 2011 Dec; 113(10):823-9. PubMed ID: 21962800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of relevance of
    Alves Do Rego C; Namer IJ; Marcel C; Lefebvre F; Lagha-Boukbiza O; Renaud M; Tranchant C; Anheim M
    J Neurol; 2018 Sep; 265(9):2033-2039. PubMed ID: 29956027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac ¹²³I-MIBG scintigraphy as an outcome-predicting tool for subthalamic nucleus stimulation in Parkinson's disease.
    Yamada K; Shiraishi SY; Hamasaki T; Kuratsu J
    Acta Neurochir (Wien); 2010 Dec; 152(12):2063-8. PubMed ID: 20927559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
    Lee EA; Kim BJ; Lee WY
    Mov Disord; 2002 Nov; 17(6):1242-7. PubMed ID: 12465063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy.
    Oka H; Mochio S; Yoshioka M; Morita M; Onouchi K; Inoue K
    Acta Neurol Scand; 2006 Apr; 113(4):221-7. PubMed ID: 16542160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy.
    Nagayama H; Ueda M; Yamazaki M; Nishiyama Y; Hamamoto M; Katayama Y
    Mov Disord; 2010 Aug; 25(11):1744-7. PubMed ID: 20645402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy.
    Köllensperger M; Seppi K; Liener C; Boesch S; Heute D; Mair KJ; Mueller J; Sawires M; Scherfler C; Schocke MF; Donnemilier E; Virgolini I; Wenning GK; Poewe W
    Mov Disord; 2007 Sep; 22(12):1771-6. PubMed ID: 17579357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
    Rouco I; Gómez JC; Lezcano E; Aniel-Quiroga MA; Velasco F; Barcena J; Pérez Bas M; Hurtado P; Cruz Lachén M; Zarranz JJ
    Neurologia; 2006 Apr; 21(3):119-23. PubMed ID: 16575624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis.
    Orimo S; Suzuki M; Inaba A; Mizusawa H
    Parkinsonism Relat Disord; 2012 Jun; 18(5):494-500. PubMed ID: 22321865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.